Question · asked by 1 review

Long‐term red cell transfusion vs hydroxyurea and phlebotomy: Measures of neurological impairment ‐ not reported

Population
individuals with sickle cell disease who have had a stroke who have had long‐term red cell transfusions to prevent another stroke
Intervention
Long‐term red cell transfusion
Comparison
hydroxyurea and phlebotomy
Outcome
Measures of neurological impairment ‐ not reported

The review found no eligible studies for this question.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Long‐term red cell transfusion vs hydroxyurea and phlebotomy
Measures of neurological impairment ‐ not reported · individuals with sickle cell disease who have had a stroke who have had long‐term red cell transfusions to prevent…
The review found no eligible studies for this question.
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease (2020) · Cochrane Headline outcomes only
no estimate extractedNot reportedNo studies found

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
2020 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.